金城医药(300233.SZ)：乳糖酸红霉素化学原料药上市申请获批准

Group 1 - The core point of the article is that Jincheng Pharmaceutical has received approval for its chemical raw material drug, Lactobionic Acid Erythromycin, from the National Medical Products Administration [1] - The drug is an antibiotic belonging to the macrolide class, used for treating severe infectious diseases [1]